ABCB1 and breast cancer: Vialenin P (VP) can suppress PI3K/Nrf2 signaling to down-regulate multidrug resistance protein 1 (MRP1), leading to enhanced accumulation of DOX in breast cancer cells, and sensitizing them to chemotherapy [182].